next-generation-sequencing
(3)
Sasan Amini
Sasan Amini is the co-founder and CEO of Clear Labs, a San Carlos genomics company that turns next-generation DNA sequencing into a push-button diagnostic for food safety and infectious disease. An Iranian immigrant who left Tehran at 22, he earned a PhD in genomics at Princeton, worked in advanced research at Illumina, and in 2014 set out to make sequencing simple enough for any lab to run. When COVID-19 hit, Clear Labs pivoted its automated platform into SARS-CoV-2 surveillance and reached more than half of U.S. public health labs.
Shidong Jia
Shidong Jia, MD, PhD, is the founder and global CEO of Predicine, a Silicon Valley precision-oncology company building multi-omic liquid biopsy tests that read cancer from blood and urine. Trained as a physician-scientist at Harbin Medical University, Peking Union Medical College, Dana-Farber and Harvard, he ran oncology biomarker strategy at Genentech before leaving to start Predicine in 2015. His pitch is simple: precision diagnostics to enable precision medicine, built 'From Pharma, For Pharma.'
Marc Montserrat
Marc Montserrat is the Chief Executive Officer of DNA Script, a French-American biotech pioneering enzymatic DNA synthesis - a technology that lets labs print custom DNA on demand, in hours instead of days. A Wharton MBA and industrial engineer by training, Montserrat spent two decades building commercial operations at Ariosa Diagnostics (prenatal testing), Omniome (next-gen sequencing), and Deepcell (AI-powered single-cell analysis) before co-founding Splice Bio and ultimately landing as CEO of DNA Script in October 2024. He was drawn into life sciences after a misdiagnosis scare at 24 that convinced him life was too short to spend on work without meaning.